DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Heeschen C, Hamm CW, Mitrovic V. et al.
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Circulation 2004; 110: 3206-3212
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.